Since IN I-PP O
the DT I-NP O
receptors NNS I-NP O
in IN I-PP O
human JJ I-NP O
biology NN I-NP O
mostly RB O O
consist VBZ I-VP O
of IN I-PP O
chiral JJ I-NP I-M
molecules, JJ I-NP I-M
drug NN I-NP O
action NN I-NP O
mostly RB O O
involves VBZ I-VP O
a DT I-NP O
specified JJ I-NP O
enantiomeric JJ I-NP O
form. NN I-NP O

This DT I-NP O
has VBZ I-VP O
spurred VBN I-VP O
the DT I-NP O
development, NN I-NP O
especially RB O O
in IN I-PP O
the DT I-NP O
pharmaceutical JJ I-NP O
industry, NN I-NP O
of IN I-PP O
a DT I-NP O
host NN I-NP O
of IN I-PP O
techniques NNS I-NP O
to TO I-VP I-T
secure VB I-VP I-T
enantiopure NN I-NP I-T
products. NN I-NP I-T

Such JJ I-NP O
methods, NNS I-NP I-P
mostly RB O I-P
and CC O I-P
can MD I-VP O
typically RB I-VP O
be VB I-VP O
cast VBN I-VP O
in IN I-PP O
one CD I-NP O
of IN I-PP O
two CD I-NP O
distinct JJ I-NP O
categories: NNS I-NP O
synthetic JJ I-NP I-P
mechanisms NNS I-NP I-P
designed VBN I-VP O
to TO I-VP O
produce VB I-VP O
a DT I-NP O
single JJ I-NP O
stereoisomer, NN I-NP I-M
or CC O O
separation NN I-NP I-P
techniques NNS I-NP I-P
to TO I-VP O
isolate VB I-VP O
distinct JJ I-NP O
enantiomers NNS I-NP I-M
from IN I-PP O
a DT I-NP O
racemic JJ I-NP O
mixture. NN I-NP O

A DT I-NP O
significant JJ I-NP O
drawback, NN I-NP O
for IN I-PP O
either DT I-NP O
approach, NN I-NP O
is VBZ I-VP O
a DT I-NP O
dependence NN I-NP O
on IN I-PP O
a DT I-NP O
supply NN I-NP O
of IN I-PP O
enantiopure NN I-NP I-M
reagents NNS I-NP I-M
or CC O I-M
substrates NNS I-NP I-M
– VBP I-VP O
synthesis NN I-NP I-P
routes NNS I-NP I-P
generally RB O O
utilise JJ I-NP O
chiral JJ I-NP I-M
building NN I-NP I-M
blocks NNS I-NP I-M
or CC O O
enantioselective JJ I-NP I-M
catalysts NNS I-NP I-M
[7,8], VBP I-VP O
while IN I-PP O
enantiomer JJ I-NP I-P
separation NN I-NP I-P
techniques NNS I-NP I-P
typically RB O O
incorporate VBP I-VP O
chiral JJ I-NP I-M
selector NN I-NP I-M
molecules NNS I-NP I-M
to TO I-VP O
form VB I-VP O
chemically RB O O
distinct JJ I-NP O
and CC O O
distinguishable JJ I-NP O
diastereomeric NN I-NP I-M
complexes NNS I-NP I-M
[8,9]. VBP I-VP O

A DT I-NP O
key JJ I-NP O
requirement NN I-NP O
in IN I-PP O
aiming VBG I-VP O
to TO I-VP O
achieve VB I-VP I-T
enantiopure NN I-NP I-T
products, JJ I-NP I-T
irrespective NN I-NP I-T
of IN I-PP I-T
the DT I-NP I-T
synthetic JJ I-NP I-P
method, NN I-NP I-P
is VBZ I-VP O
therefore RB I-VP O
a DT I-NP O
means NN I-NP I-T
to TO I-VP I-T
measure, VB I-VP I-T
and CC I-VP I-T
duly VB I-VP I-T
quantitate VB I-VP I-T
the DT I-NP I-T
enantiomeric JJ I-NP I-T
excess NN I-NP I-T
– NN I-NP O
signifying VBG I-VP O
the DT I-NP O
degree NN I-NP I-P
of IN I-PP I-P
chirality NN I-NP I-P
within IN I-PP O
molecular JJ I-NP I-M
products. NN I-NP I-M

Chiral JJ I-NP I-P
discrimination NN I-NP I-P
through IN I-PP O
optical JJ I-NP I-M
means NNS I-NP I-M
is VBZ I-VP O
to TO I-VP O
offer VB I-VP O
direct, JJ I-NP O
ways NNS I-NP O
to TO I-VP O
distinguish VB I-VP O
between IN I-PP O
molecules NNS I-NP I-M
of IN I-PP O
different JJ I-NP O
handedness, NNS I-NP O
based VBN I-VP O
on IN I-PP O
observations NNS I-NP O
such JJ I-NP O
as IN I-PP O
the DT I-NP O
subtle JJ I-NP O
differences NNS I-NP O
in IN I-PP O
absorption NN I-NP I-P
of IN I-PP O
and CC O O
circularly NN I-NP O
polarised VBN I-VP O
light, NN I-NP O
or CC O O
indeed RB O O
the DT I-NP O
twisting NN I-NP I-P
of IN I-PP I-P
polarisation NN I-NP I-P
in IN I-PP I-P
optical JJ I-NP I-P
rotation. NN I-NP I-P

Other JJ I-NP O
optical JJ I-NP I-P
methods, NN I-NP I-P
under IN I-PP O
more RBR I-NP O
recent JJ I-NP O
development, NN I-NP O
also RB O O
show VBP I-VP O
some DT I-NP O
promise NN I-NP O
to TO I-VP O
achieve VB I-VP O
enantiomer NN I-NP I-T
separation, NN I-NP I-T
as IN I-PP O
will MD I-VP O
be VB I-VP O
introduced VBN I-VP O
later. NN I-NP O

